Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial

Table 3 Score of various individual domains of World Health Organisation Quality of Life Questionnaire at baseline and 12 weeks in the two study groups

Domain	Group	0 week	12 weeks	P value
Physical	Group A	39.44 ± 11.32	54.40 ± 11.69	< 0.0001a
	Group B	37.44 ± 11.21	33.40 ± 11.87	0.0131a
Psychological	Group A	32.80 ± 11.43	47.72 ± 9.34	< 0.0001a
	Group B	33.48 ± 9.99	28.04 ± 12.56	0.0098a
Social	Group A	33.16 ± 17.61	45.76 ± 14.02	< 0.0001a
	Group B	40.28 ± 14.65	36.76 ± 15.81	0.075
Environmental	Group A	32.6 ± 14.24	45.68 ± 13.07	< 0.0001a
	Group B	38.4 ± 13.26	33.08 ± 14.67	0.004a

^aP < 0.05.